Exane Derivatives’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Exane Derivatives's OGN Position: Q2 2022 in Review
Exane Derivatives opened a new position in Organon & Co (OGN) in Q2 2022: 7,781 shares worth $263K. The stake represents 0.15% of the portfolio and ranks #138 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in OGN as recently as Q4 2021.
Exane Derivatives first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. The position peaked at $793K in Q3 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.
- Exane Derivatives held 7,781 shares of Organon & Co worth $263K as of Q2 2022.
- Organon & Co was a new Exane Derivatives position in Q2 2022.
- Organon & Co made up 0.15% of Exane Derivatives's portfolio in Q2 2022, its #138 holding.
- Exane Derivatives first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
- Exane Derivatives's Organon & Co position peaked at $793K in Q3 2021.
- 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.